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Abstract
Background: Osteoarthritis (OA) is a common degenerative joint disease causing pain, stiffness, reduced motion,
swelling, crepitus, and disability. Dickkopf-1 (Dkk-1) is a critical mediator of osteoblastogenesis and regulates the
joint remodeling. The aim of this study was to examine plasma and synovial fluid Dkk-1 levels of patients with
primary knee OA and to investigate their relationship with disease severity.
Methods: Thirty-five patients aged 55-83 years with knee OA and 15 healthy individuals were recruited into this
study. Disease severity was determined using weight-bearing anteroposterior radiographs of the affected knee. The
radiological grading of OA in the knee was performed according to the Kellgren-Lawrence grading system. Dkk-1
levels in both plasma and synovial fluid were evaluated using enzyme-linked immunosorbent assay.
Results: The average concentration of circulating Dkk-1 in the knee OA patients was remarkably lower than that of
healthy controls (396.0 ± 258.8, 95%CI 307.1-484.9 vs 2348.8 ± 2051.5, 95%CI 1164.3-3533.3 pg/ml, p < 0.0001).
Dkk-1 levels in synovial fluid were significantly lower than in paired plasma samples (58.6 ± 31.8, 95%CI 47.7-69.6 vs
396.0 ± 258.8, 95%CI 307.1-484.9 pg/ml, p < 0.001). Furthermore, both plasma and synovial fluid Dkk-1 levels were
inversely correlated with radiographic severity (r = -0.78, p < 0.001 and r = -0.42, p = 0.01, respectively). Plasma
Dkk-1 levels were also significantly correlated with synovial fluid Dkk-1 levels (r = 0.72, p < 0.001).
Conclusions: Dkk-1 levels in plasma and synovial fluid are inversely related to the severity of joint damage in knee
OA. Dkk-1 could serve as a biochemical marker for determining disease severity and might play a potential role in
the pathogenesis of the degenerative process of OA.
Background
Osteoarthritis (OA) is the most prevalent joint disease
causing pain, stiffness, reduced motion, swelling, crepitus,
and disability. It is characterized by the progressive
destruction of articular cartilage with joint-space narrow-
ing, osteophyte formation, subchondral sclerosis, and
synovitis [1]. The knee is the most clinically significant
site of primary osteoarthritis involvement. One of the
current methods to evaluate the affected joint is radiolo-
gical assessment which reflects disease severity by grad-
ing the joint degeneration. The Kellgren-Lawrence
grading scale representing disease severity has been the
most widely used system [2]. The etiology and pathogen-
esis of OA remain poorly understood, but have been
associated with several physiological factors such as obe-
sity and aging [3]. Nevertheless, biochemical factors have
by now been recognized as playing an important role in
OA development.
Secreted glycoproteins of the Wingless (Wnt) signaling
pathway are crucial regulators of cell growth and survi-
val in a variety of human cell types. Wnt ligands bind to
a receptor complex encompassing a member of the
Frizzled family of seven transmembrane proteins and
the co-receptor, low-density lipoprotein (LDL) receptor-
related proteins (LRP5/6) [4]. In the canonical Wnt/
b-catenin signaling pathway, receptor activation results
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translocates into the nucleus to activate target gene
expression. Dickkopf-1 (Dkk-1) is a secreted protein
that has been defined as a direct inhibitor of Wnt/
b-catenin signaling by interacting with the LRP5/6 co-
receptors of frizzled [5,6]. Dkk-1 is a critical mediator of
osteoblastogenesis and regulates the formation of the
skeleton during the development of the embryo [7].
More recent studies have suggested a potential role of
Dkk-1 in malignant bone disease and arthritis [8-10].
Uderhardt et al. have shown that inhibition of Dkk-1
effectively reduces bone erosion of sacroiliac joints [11].
In addition, Diarra and colleagues have documented
that blockade of Dkk-1 reverses the bone-destructive
pattern in a mouse model of rheumatoid arthritis to the
bone-forming pattern of OA [10], indicating that Dkk-1
is a central regulator of joint remodeling. Recently, ele-
vated circulating Dkk-1 levels have been associated with
delayed progression of radiographic hip OA in women
[12]. Furthermore, growing evidence has proposed an
association between deregulated Wnt signaling compo-
nents and joint disorders in OA cartilage chondrocyte
cultures [13].
Even though circulating and/or synovial fluid levels of
several cytokines have been investigated in patients with
knee OA, there have not been any reports on the associa-
tion of circulating and synovial fluid levels of Dkk-1 with
disease activity in primary knee OA [14-18]. We have
hypothesized that Dkk-1 in plasma and synovial fluid
might be associated with the severity of clinical outcomes
in knee OA patients. To prove this hypothesis, we have
investigated the plasma and synovial fluid levels of Dkk-1
in knee OA patients and healthy controls. The aim of the
present study was to evaluate, for the first time in the lit-
erature, both plasma and synovial fluid levels of Dkk-1 in
patients with primary knee OA, and examine the possible
relationships between plasma and synovial fluid Dkk-1
with the radiographic grading of knee osteoarthritis.
Methods
Study participants
This study was approved by the Institutional Review
Board on Human Research of the Faculty of Medicine,
Chulalongkorn University and was conducted in agree-
ment with the Declaration of Helsinki. Written informed
consent was obtained from the patients and healthy
volunteers prior to their participation in this study.
Thirty-five patients aged 55 to 83 years with primary
knee osteoarthritis (26 females and 9 males; mean age
68.8 ± 8.2 years) according to the criteria of the American
College of Rheumatology were enrolled in the study. The
severity of the disease was determined using weight-
bearing anteroposterior radiographs of the affected
knee. Knee radiographs were evaluated according to the
Kellgren and Lawrence classification [2]: grade 1, doubtful
narrowing of joint space and possible osteophytic lipping;
grade 2, definite osteophytes and possible narrowing of
joint space; grade 3, moderate multiple osteophytes, defi-
nite narrowing of joint space, some sclerosis and possible
deformity of bone contour; grade 4, large osteophytes,
marked narrowing of joint space, severe sclerosis and defi-
nite deformity of bone contour. The grading scale used for
analysis was the one found higher upon comparison
between both knees. We also recruited 15 gender and
age matched subjects (10 females and 5 males; mean age
67.5 ± 4.6 years) with normal knee radiographs as con-
trols. None of the participants had underlying diseases
such as diabetes, histories of corticosteroid medication,
other forms of arthritis, cancer, or other chronic inflam-
matory diseases.
Laboratory methods
Synovial fluid was aspirated from the affected knee using
s t e r i l ek n e ep u n c t u r ej u s tp r i o rt os u r g e r y ,w h e nat o t a l
knee replacement was performed, centrifuged to remove
cells and joint debris and stored immediately at -80°C
until the day of measurement. No synovial fluid was
extracted from the controls due to ethical concerns.
Venous blood samples collected from the same patients
on the day of surgery were centrifuged and stored at -80°C
until utilized. Double-blind quantitative detection of
Dkk-1 in plasma and synovial fluid was performed by
sandwich enzyme-linked immunosorbent assay (ELISA)
using a commercially available test kit according to the
manufacturer’s protocol (Quantikine, R&D Systems, Min-
neapolis, MN). Briefly, standards of recombinant human
Dkk-1, plasma, and synovial fluid samples prediluted 1:4
in assay buffer were added to 96-well microtiter plates pre-
coated with mouse monoclonal antibody against Dkk-1
and incubated for 2 hours at room temperature. The wells
were then washed four times with washing buffer and
incubated for 2 hours at room temperature with a horse-
radish peroxidase-conjugated goat polyclonal antibody
against Dkk-1. After four washes, substrate solution was
added to each well, and the plate was incubated for
30 minutes at room temperature in the dark. Finally, the
reaction was stopped with the stop solution, and absor-
bance was measured at 450 nm using an automated
microplate reader. Recombinant human Dkk-1 was used
to generate a linear standard calibration curve (range 31.2-
2,000 pg/ml). The manufacturer-reported precision
was 3.3-4.2% (intra-assay) and 4.6-7.6% (inter-assay). The
sensitivity of this assay was 4.2 pg/ml.
Statistical analysis
Statistical analysis was carried out using the statistical
package for social sciences (SPSS) software, version 16.0
for Windows. Tests of normality and test of homogeneity
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age, body mass index (BMI) and Dkk-1 concentration in
the plasma and synovial fluid. The analysis of co-variance
(ANCOVA) indicated that age, gender and BMI were not
potentially confounding factors in the study. Demo-
graphic data between patients and controls were com-
pared by Chi-square tests and unpaired Student’s t tests,
where appropriate. Comparisons between the groups
were performed using one-way analysis of variance
(ANOVA) with Tukey post hoc test if ANOVA showed
significance. Comparisons between groups were made
using Mann-Whitney U test (for two groups) or Kruskal-
Wallis test (for more than two groups) when the var-
iances were not equal among the groups. Pearson’s corre-
lation coefficient was employed to determine the
correlation among the concentration of Dkk-1 in the
plasma and synovial fluid and the disease severity. Sensi-
tivity, specificity, receiver-operating characteristic (ROC)
curves were also determined. P values < 0.05 were con-
sidered to be statistically significant for differences and
correlations. All values are expressed as mean ± standard
deviation (SD) and 95% confidence intervals (95%CI).
Results
Thirty-five plasma and synovial fluid samples from knee
OA patients and 15 plasma samples from healthy con-
trols were acquired for measurement of Dkk-1 concen-
trations. Characteristics of the study population are
shown in Table 1. There was no clinically meaningful
difference in age between OA patients and controls
(68.8 ± 8.2, 95%CI 66.3-70.5 vs 67.5 ± 4.6, 95%CI 65.3-
70.3 years, p = 0.6). In addition, the female/male ratio
was 26/9 in patients and 10/5 in controls (p = 0.1). The
study population was adjusted for age and gender.
T h e r ew a sn os i g n i f i c a n td i f f e r e n c ei nb o d ym a s si n d e x
between OA patients and controls (26.6 ± 3.8, 95%
CI 25.3-28.0 vs 25.5 ± 1.3, 95%CI 24.6-26.4 kg/m
2,
p = 0.3). As demonstrated in Figure 1, OA patients had
lower plasma Dkk-1 concentrations compared to
healthy controls (396.0 ± 258.8, 95%CI 307.1-484.9 vs
2348.8 ± 2051.5, 95%CI 1164.3-3533.3 pg/ml, p <
0.0001). Dkk-1 levels in synovial fluid were significantly
lower than in paired plasma samples (58.6 ± 31.8, 95%
CI 47.7-69.6 vs 396.0 ± 258.8, 95%CI 307.1-484.9 pg/ml,
p < 0.001). In the OA group, there were no differences
in Dkk-1 levels between males and famales in either
plasma (400.7 ± 275.1, 95%CI 291.9-509.5 vs 380.1 ±
209.1, 95%CI 205.3-555.0 pg/ml, p = 0.8) or synovial
fluid (72.1 ± 60.2, 95%CI 21.8-122.5 vs 54.6 ± 16.6, 95%
CI 48.1-61.2 pg/ml, p = 0.5). In the control group,
plasma Dkk-1 concentrations were not significantly dif-
ferent between both genders (1831.7 ± 1174.7, 95%
CI 373.1-3290.3 vs 2636.1 ± 2426.8, 95%CI 770.6-
4501.5 pg/ml, p = 0.4).
According to the Kellgren and Lawrence (KL) classifi-
cation, 10 patients were KL grade 2, whereas 12 patients
were KL grade 3, and 13 patients were KL grade 4
osteoarthritis. The circulating and synovial fluid levels of
Dkk-1 were assessed and compar e di na s s o c i a t i o nw i t h
radiological KL grading of OA. The plasma Dkk-1 levels
from KL grade 2 were 711.4 ± 248.0, 95%CI 534.0-888.9
Table 1 Characteristics of knee osteoarthritis patients and controls
Controls
(95%CI)
OA patients
(95%CI)
Total KL grage 2 KL grade 3 KL grade 4
N 1 5 3 5 1 01 21 3
Age (years) 67.5 ± 4.6 68.8 ± 8.2 68.8 ± 6.8 68.1 ± 8.3 69.5 ± 7.5
(65.3-70.3) (66.3-70.5) (63.9-73.6) (61.5-74.6) (64.9-73.9)
Female/Male 10/5 26/9 7/3 9/3 10/3
BMI (kg/m
2) 25.5 ± 1.3 26.6 ± 3.8 26.2 ± 1.4 26.4 ± 3.1 27.2 ± 4.8
(24.6-26.4) (25.3-28.0) (25.2-27.2) (24.5-28.4) (23.7-30.7)
Data are expressed as mean and SD.
BMI = Body mass index.
KL = Kellgren and Lawrence.
Figure 1 Plasma Dkk-1 levels of patients with osteoarthritis
(n = 35) and healthy controls (n = 15).
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CI 272.1-408.1 pg/ml; and those from KL grade 4 were
204.9 ± 86.6, 95%CI 152.6-257.2 pg/ml (Figure 2). These
results showed that plasma Dkk-1 levels in KL grade 3
and 4 were significantly lower than those of KL grade 2
(p < 0.001). Although the mean plasma levels of Dkk-1
in KL grade 4 were lower than those in KL grade 3, the
difference was not significant (p = 0.1). Furthermore,
the synovial fluid levels of Dkk-1 from KL grade 2 were
77.3 ± 51.7, 95%CI 40.3-114.3 pg/ml; those from KL
grade 3 were 58.4 ± 16.1, 95%CI 48.1-68.6 pg/ml; and
those from KL grade 4 were 44.5 ± 10.6, 95%CI 38.1-
50.9 pg/ml (Figure 3). The data showed that synovial
fluid Dkk-1 levels in KL grade 2 and 3 were significantly
elevated compared with those of KL grade 4 (p = 0.04).
Although synovial fluid Dkk-1 levels in KL grade 2 were
elevated compared with those of KL grade 3, the differ-
ence was not significant (p = 0.4). We further analyzed
the correlation between the plasma and synovial fluid
levels of Dkk-1 and the severity of osteoarthritis. Intri-
guingly, plasma Dkk-1 levels were negatively correlated
with the radiographic grading of knee OA (r = -0.78, p
< 0.001) (Figure 2). Synovial fluid levels of Dkk-1 were
weakly associated with the radiographic severity of dis-
ease (r = -0.42, p = 0.01) (Figure 3). Figure 4 reveals
that a rough estimate of plasma Dkk-1 levels in OA
patients is 200-400 pg/ml whereas that of synovial fluid
Dkk-1 levels is 25-70 pg/ml. However, plasma Dkk-1
levels showed a positive correlation with synovial fluid
Dkk-1 levels (r = 0.72, p < 0.001). Using ROC curves
drawn with data of our results, the cutoff value was set
to provide optimal diagnostic accuracy and likelihood
ratios for Dkk-1 protein. A plasma level of 459.5 pg/ml
was with a sensitivity of 90% and a specificity of 92% for
moderate knee OA (KL grade 3). A plasma level of
303.5 pg/ml was with a sensitivity of 77% and a specifi-
city of 85% for advanced knee OA (KL grade 4).
Discussion
The Wnt signaling pathway plays an essential role in cell
patterning, proliferation, differentiation, and fate deter-
mination during embryogenesis and therefore it is not
surprising that Wnt modulators, including Dkks are also
involved. Dkk is a family of cysteine-rich proteins con-
sisting of Dkk-1, Dkk-2, Dkk-3, Dkk-4 and a unique
Figure 2 Scattergram showing the inverse correlation between
plasma Dkk-1 levels in patients with OA and severity classified
according to Kellgren and Lawrence grading scale (r = -0.78,
p < 0.001).
Figure 3 Scattergram showing the negative correlation
between synovial fluid Dkk-1 levels in patients with OA and
severity classified according to Kellgren and Lawrence grading
scale (r = -0.42, p = 0.01).
Figure 4 Scattergram showing the positive correlation
between plasma and synovial fluid Dkk-1 concentrations in OA
patients (r = 0.72, p < 0.001).
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ural antagonist of the Wnt signaling pathway and plays
substantial roles in vertebrate embryogenesis including
head induction, skeletal development, and limb pattern-
ing [20,21]. Deletion of a single allele of Dkk-1 enhances
bone mass in mice [22]. A recent study has demonstrated
that aberrant expression of Dkk-1 in myeloma cells was
associated with increased bone erosion in human multi-
ple myeloma [23]. Therefore, expression of Dkk-1 in
inflammatory and degenerative joint diseases may block
bone formation within the joint.
It has been previously demonstrated that circulating
Dkk-1 is present in rheumatoid arthritis, ankylosing
spondylitis, and osteoarthritis [24-26]. However, the
association between circulating and synovial fluid levels
of Dkk-1 and disease severity has never been specifically
evaluated in knee OA patients. To our knowledge, data
on the relationship between Dkk-1 levels in plasma and
synovial fluid and severity of knee OA have as yet not
been reported in the literature. This study has been the
first to illustrate that Dkk-1 was detected in both plasma
and synovial fluid derived from patients with primary
knee OA, and that Dkk-1 were inversely related to
radiographic grading of knee OA.
The most intriguing finding in this study has been that
concentrations of Dkk-1 were decreased in plasma of
patients with primary knee OA compared to the controls.
Our results suggest that there is reduced systemic pro-
duction of Dkk-1 in knee OA. It should be noted that
Dkk-1 levels in synovial fluid were significantly lower
than those seen in paired plasma samples. The source of
Dkk-1 could be derived from the local tissues (inflamed
synovium, cartilage, and subchondral bone) and extra-
articular tissues. Previous studies have shown that Dkk-1
was expressed in synovial cells, articular cartilage chon-
drocytes and subchondral bone osteoblasts in OA knees
[10,27,28]. Dkk-1 levels in plasma and synovial fluid were
measured in a well-defined knee OA population at every
stage of disease, and were significantly lower in end-stage
knee OA patients compared with early OA patients. This
observation suggests a significant reduction in the sys-
temic and local expression of Dkk-1 in patient with
advanced knee OA. The mechanisms of Dkk-1 reduction
in the circulation and synovial fluid of OA patients
remain to be investigated further.
In concordance with our findings, Voorzanger-Rousse-
lot and coworkers have revealed that circulating Dkk-1
levels were lower in patients with knee OA compared
with healthy controls [26]. In our study circulating and
synovial fluid levels of Dkk-1 were higher in early knee
OA patients (KL grade 2) compared to end-stage knee
OA (KL grade 4), in agreement with Lane’s observation.
Recently, Lane and colleagues have documented that
increased circulating levels of Dkk-1 appeared to be
associated with delayed progression of radiographic hip
OA in elderly women [12]. Dkk-1 has been demonstrated
to delay new bone formation and subchondral bone
remodeling and is a potent negative regulator of osteo-
blast differentiation [22,23]. Therefore, the mild/moderate
knee OA patients with high circulating and synovial fluid
levels of Dkk-1 may reflect the Dkk-1 capability to inhibit
bone remodeling around the osteoarthritic joint. It is
interesting to postulate that Dkk-1 might be able to delay
articular cartilage loss. In this study, patients with
advanced articular cartilage loss were found to be the
subgroup with the lowest circulating and synovial fluid
levels of Dkk-1. Previous reports have demonstrated that
increased Dkk-1 levels were correlated with the patho-
genesis of joint disorders [10,26,27]. In this study, Dkk-1
levels were decreased in direct relation to the severity of
knee OA. Moreover, plasma Dkk-1 in OA patients was
remarkably lower than in controls. These conflicting
results may be attributable to differences in disease
advancement, populations or assays applied, or to incom-
plete control of confounding variables.
It is interesting to point out that in a mouse model of
osteoarthritis [27] and in human OA patients [28,29]
the loss of a souble Wnt antagonist, frizzled-related pro-
tein-3, was associated with enhanced cartilage damage,
plausibly by modulating the activity of chondrocytes
[30]. This may provide an explanation for the inverse
correlation between Dkk-1 and disease severity in pri-
mary knee OA patients. Furthermore, decreased Dkk-1
levels tend to be essential for osteophyte formation, sug-
gesting that Wnt signaling is a critical initiator for bone
formation in the joint. Local bone formation in the pre-
sence of osteophyte formation is a hallmark of degen-
erative joint diseases including osteoarthritis [10].
Additional studies will be required to determine whether
the concentrations of Dkk-1 in synovial fluid and plasma
are related to the expression of Dkk-1 in joint tissues.
The mechanisms underlying Dkk-1 reduction in the cir-
culation and synovial fluid of OA patients remain to be
further investigated.
In this study, we have been aware of several potential
limitations. First, our study was based on a small sample
size of enrolled patients. A further study conducted on a
random sample of a larger population will be needed to
substantiate our results. Secondly, only Dkk-1 concen-
tration has been measured in both plasma and synovial
fluid. Additional immunohistochemical investigations of
Dkk-1 expression could provide further valuable infor-
mation on the pathogenic role of Dkk-1 in OA. Thirdly,
we have not investigated the role of other soluble Wnt
inhibitors, such as frizzled-related protein-3, which has
been proposed to be associated with joint destruction in
OA [31,32]. Moreover, the daily variation of plasma
Dkk-1 has yet to be fully determined and it is unclear
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(walking, jumping, eating, etc.). Therefore, diurnal and
activity-related variations in plasma Dkk-1 will be
needed to be further evaluated. Finally, as this study has
been designed as a cross-sectional study it is not possi-
ble to determine a definite cause and effect relationship
and to arrive at a strong conclusion. However, prospec-
tive longitudinal studies are warranted to demonstrate
disease progression and define the exact role of Dkk-1
in knee OA.
Conclusions
This study has revealed a significant decrease in plasma
Dkk-1 of OA patients and illustrated a pronounced
inverse correlation with the degree of radiographic
severity in patients with primary knee OA. The data of
this study support the finding that Dkk-1 may be a use-
ful prognostic parameter to reflect the disease severity
of primary knee OA. In addition, Dkk-1 levels in plasma
were directly correlated with those in synovial fluid.
This study has been the first to investigate such a corre-
lation and further studies will be required to define the
mechanisms underlying this association. Additional
investigations will be required to shed light on the pos-
s i b l er o l eo fD k k - 1i n v o l v e di nt h ep a t h o g e n e s i so f
chronic degenerative joint disorder, with the aim of
developing effective pharmacological agents to delay the
progression to osteoarthritis.
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